Mirtazapina Aurobindo (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine, and by antagonising postsynaptic 5‑HT2 and 5‑HT3 receptors, enhancing serotonergic activity. Its additional H1‑receptor blockade contributes to sedative effects, together producing antidepressant and anxiolytic actions.

The exact dose of Mirtazapina Aurobindo is determined by the prescribing clinician based on the individual’s clinical condition, age, and response to therapy. Typical starting doses may be low and are often titrated upward, but the specific regimen should always follow the prescriber’s instructions.

Safety data for mirtazapine in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers usually assess each case individually and may recommend alternative treatments when safer options are available.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Mirtazapina Aurobindo. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapine belongs to the NaSSA class, differing from selective serotonin reuptake inhibitors (SSRIs) that primarily block serotonin reuptake. Its combined noradrenergic and serotonergic activity, plus strong antihistamine effects, often results in pronounced sedation and appetite stimulation, which can be advantageous for patients with insomnia or weight loss, but may be less suitable for those prone to weight gain.

Mirtazapina Aurobindo should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

The medication is taken orally, usually once daily in the evening because of its sedative properties. It can be swallowed whole with water and may be taken with or without food, unless the prescriber advises otherwise.

Serious adverse events include agranulocytosis or severe neutropenia, potentially life‑threatening allergic reactions such as Stevens‑Johnson syndrome, and worsening of mood leading to suicidal thoughts, especially during early treatment or dose changes. Prompt medical attention is required if any of these symptoms appear.

Mirtazapina Aurobindo is contraindicated in individuals with known hypersensitivity to mirtazapine or any of its excipients, and in patients currently taking monoamine oxidase inhibitors (MAOIs) or who have taken an MAOI within the past 14 days. Caution is also advised for those with severe hepatic impairment or uncontrolled hypertension.